Connect with us

European Commission

Commission clears the acquisition of Syneos Health by Veritas, EIM and Patient Square

SHARE:

Published

3 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control of Syneos Health, Inc. by Veritas Capital Fund Management, L.L.C (‘Veritas'), Elliott Investment Management L.P. (‘EIM') and Patient Square Capital L.P. (‘Patient Square'), all of the US.

Syneos Health isa global contract research and outsourced commercialization organization providing services to pharmaceutical and biotechnology firms. Veritas is a private equity fund investing in companies that provide critical products, software and services to government as well as to commercial customers worldwide. EIM is an investment manager company. Patient Square is a dedicated health care investment firm.

The Commission concluded that the proposed acquisition would raise no competition concerns, given the absence of horizontal overlaps and limited vertical links between the companies' activities in the European Economic Area. The transaction was examined under the simplified merger review procedure.

More information is available on the Commission's competition website, in the public case register under the case number M.11170.

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending